New User? Click here to register

VAB and VAE: To sample or to excise?

ABSTRACT

Text generated by AI based on an exclusive interview, revised and reviewed by

Dr Jean-Philippe MINART, Cannes, France

October 20, 2023

Thoughts on DESTINY-Breast04 for HER2-low metastatic breast cancer.
Joseph GLIGOROV
Oncologist, Paris, France
Where does immunotherapy take place in breast cancer, is there a potential in HER2 positive patients?
Hassan GHAZAL
oncologist, Dubai
The impact of race and ethnicity in Breast cancers: disparities and implications for BC screening.
Thu Ha DAO
Radiologist, Créteil, France
Preoperative assessment: How far to go in imaging?
Dalila AHNOU
Can you discuss de-escalation of adjuvant radiotherapy in woman with early breast cancer?
Yazid BELKACEMI
radiotherapist, Créteil, France